The LLPS inhibitor 1,6‐hexanediol can downregulate MYC transcription levels and inhibit pancreatic cancer growth, which may be related to the disruption of the MYC super enhancer's function. The gene discussed is MYC; the disease is familial pancreatic carcinoma.